A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX

Trial Profile

A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Folitixorin (Primary) ; Methotrexate
  • Indications Folic acid deficiency; Osteosarcoma
  • Focus Therapeutic Use
  • Acronyms FORTO
  • Sponsors Isofol Medical
  • Most Recent Events

    • 02 Sep 2016 Status changed from recruiting to completed.
    • 24 Aug 2015 Planned End Date changed from 1 May 2015 to 1 Nov 2015, as reported by ClinicalTrials.gov.
    • 24 Aug 2015 Planned primary completion date changed from 1 May 2015 to 1 Nov 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top